Changes in microRNA expressions before and after urological cancer treatment

Changes in microRNA expressions before and after urological cancer treatment - MicroRNA trial in urological cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041202

Enrollment

150

Registered

2020-10-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer, renal cancer, urothelial cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will undergo surgical treatment for prostate cancer patients that will undergo surgical treatment or drug treatment for kidney cancer Patients that will undergo surgical treatment or drug treatment for urothelial cancer (bladder cancer, renal ureteral cancer)

Exclusion criteria

Exclusion criteria: Patients with prostate cancer who have metastasis Patients who have undergone Neoadjuvant drug therapy for the target disease Patients who are known to have multiple cancers (excluding cases that have been treated with other cancers and have not recurred for 5 years or more) Patients who are judged to be unsuitable for participation in this study by the principal investigator/research coordinator

Design outcomes

Primary

Measure	Time frame
Changes in miRNA expression patterns before and after urological cancer treatment	—

Countries

Japan

Contacts

Public ContactYoshihisa Matsukawa

Nagoya University Graduate School of Medicine Urology

yoshi44@med.nagoya-u.ac.jp052-744-2985

Outcome results